| Code | Description | Claims | Beneficiaries | Total Paid |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
24,578 |
22,034 |
$1.96M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,679 |
7,835 |
$1.17M |
| 80050 |
General health panel |
4,398 |
3,488 |
$464K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
5,848 |
5,229 |
$456K |
| 84443 |
Thyroid stimulating hormone (TSH) |
26,492 |
23,926 |
$406K |
| 80053 |
Comprehensive metabolic panel |
39,238 |
34,799 |
$369K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,773 |
33,379 |
$202K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
18,050 |
15,941 |
$157K |
| 80061 |
Lipid panel |
27,125 |
23,491 |
$151K |
| 87631 |
|
1,346 |
1,247 |
$132K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13,071 |
11,816 |
$126K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
21,279 |
17,982 |
$126K |
| 87640 |
|
2,706 |
2,513 |
$115K |
| 86235 |
|
1,510 |
1,139 |
$94K |
| 84439 |
|
9,685 |
8,623 |
$80K |
| 80081 |
|
1,338 |
1,213 |
$76K |
| 87430 |
|
4,791 |
4,204 |
$70K |
| 83970 |
|
2,376 |
2,087 |
$68K |
| 87081 |
|
12,130 |
11,147 |
$66K |
| 85027 |
|
10,757 |
9,546 |
$58K |
| 82607 |
|
4,995 |
4,321 |
$56K |
| 86780 |
|
3,462 |
3,055 |
$56K |
| 86803 |
|
3,315 |
2,967 |
$54K |
| 84153 |
|
3,647 |
3,182 |
$46K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,072 |
5,195 |
$46K |
| 82728 |
|
6,557 |
5,803 |
$44K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
288 |
284 |
$40K |
| 86480 |
|
799 |
734 |
$40K |
| 81001 |
|
14,662 |
12,782 |
$39K |
| 82570 |
|
8,974 |
7,627 |
$39K |
| 87340 |
|
3,000 |
2,548 |
$39K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
886 |
627 |
$32K |
| 86140 |
|
7,018 |
5,944 |
$31K |
| 83540 |
|
5,109 |
4,482 |
$30K |
| 83516 |
|
3,144 |
2,656 |
$28K |
| 85651 |
|
6,161 |
5,381 |
$26K |
| 86328 |
|
634 |
578 |
$26K |
| 80069 |
|
3,319 |
2,799 |
$25K |
| 87184 |
|
2,893 |
2,589 |
$25K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
1,491 |
801 |
$24K |
| 87088 |
|
2,289 |
2,067 |
$24K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
570 |
527 |
$24K |
| 86038 |
|
1,576 |
1,327 |
$23K |
| 82043 |
|
5,850 |
4,959 |
$21K |
| 83880 |
|
1,406 |
1,198 |
$21K |
| 86225 |
|
1,864 |
1,523 |
$21K |
| 83550 |
|
2,630 |
2,299 |
$21K |
| 82784 |
|
1,732 |
1,412 |
$19K |
| 84702 |
|
2,229 |
1,624 |
$18K |
| 84481 |
|
1,939 |
1,707 |
$18K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
260 |
256 |
$18K |
| 83001 |
|
1,056 |
917 |
$18K |
| 84146 |
|
1,405 |
1,265 |
$17K |
| 86706 |
|
1,203 |
1,009 |
$16K |
| 82746 |
|
1,359 |
1,178 |
$15K |
| 86160 |
|
1,139 |
883 |
$14K |
| 80076 |
|
1,890 |
1,693 |
$14K |
| 85610 |
|
3,794 |
2,522 |
$13K |
| 80074 |
|
345 |
322 |
$13K |
| 86769 |
|
280 |
259 |
$12K |
| 84466 |
|
1,358 |
1,220 |
$11K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
131 |
123 |
$11K |
| 82105 |
|
718 |
661 |
$11K |
| 86431 |
|
1,517 |
1,269 |
$10K |
| 86850 |
|
1,964 |
1,819 |
$10K |
| 86200 |
|
932 |
763 |
$10K |
| 83735 |
|
1,563 |
1,287 |
$9K |
| 86901 |
|
2,045 |
1,888 |
$9K |
| 82950 |
|
1,865 |
1,729 |
$8K |
| 82550 |
|
1,477 |
1,272 |
$8K |
| 87070 |
|
1,451 |
1,322 |
$8K |
| 86003 |
|
886 |
768 |
$7K |
| 84156 |
|
3,268 |
2,798 |
$7K |
| 85730 |
|
1,252 |
1,097 |
$7K |
| 86593 |
|
1,760 |
1,594 |
$7K |
| 84165 |
|
686 |
592 |
$7K |
| 86900 |
|
2,052 |
1,893 |
$7K |
| 81003 |
|
3,243 |
2,928 |
$7K |
| 87505 |
|
71 |
53 |
$6K |
| 84550 |
|
1,537 |
1,374 |
$6K |
| 87522 |
Neg quan hep c or qual rna |
110 |
91 |
$6K |
| 83525 |
|
699 |
604 |
$6K |
| 86334 |
|
219 |
188 |
$6K |
| 87205 |
|
1,659 |
1,497 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
28,725 |
25,289 |
$5K |
| 87338 |
|
282 |
274 |
$5K |
| 82533 |
|
369 |
303 |
$5K |
| 86762 |
|
563 |
521 |
$4K |
| 86787 |
|
307 |
280 |
$4K |
| 83883 |
|
225 |
196 |
$4K |
| 87529 |
|
93 |
92 |
$4K |
| 83690 |
|
617 |
572 |
$4K |
| 83002 |
|
467 |
395 |
$4K |
| 82785 |
|
540 |
412 |
$4K |
| 84480 |
|
406 |
348 |
$4K |
| 82274 |
|
363 |
361 |
$4K |
| 82670 |
|
340 |
288 |
$3K |
| 81025 |
|
1,311 |
1,185 |
$3K |
| 82951 |
|
258 |
243 |
$3K |
| 87077 |
|
712 |
564 |
$3K |
| 87209 |
|
167 |
147 |
$2K |
| 85007 |
|
704 |
633 |
$2K |
| 84144 |
|
234 |
150 |
$2K |
| 83993 |
|
169 |
152 |
$2K |
| 84403 |
|
75 |
63 |
$2K |
| 84100 |
|
440 |
394 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
37 |
28 |
$2K |
| 84154 |
|
117 |
97 |
$2K |
| 81015 |
|
629 |
598 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
144 |
138 |
$1K |
| 86704 |
|
89 |
81 |
$1K |
| 87177 |
|
165 |
146 |
$1K |
| 83615 |
|
209 |
183 |
$1K |
| 82248 |
|
278 |
257 |
$998.34 |
| 86141 |
|
63 |
51 |
$995.34 |
| 86765 |
|
121 |
118 |
$949.38 |
| 86316 |
|
78 |
58 |
$796.50 |
| 86376 |
|
98 |
97 |
$790.96 |
| 87206 |
|
189 |
160 |
$776.51 |
| 86735 |
|
58 |
56 |
$703.18 |
| 87517 |
|
13 |
13 |
$672.62 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
15 |
15 |
$542.46 |
| 80306 |
|
45 |
41 |
$480.99 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
31 |
31 |
$436.43 |
| 82952 |
|
113 |
107 |
$410.61 |
| 87075 |
|
36 |
36 |
$405.54 |
| 84460 |
|
91 |
67 |
$399.70 |
| 85045 |
|
161 |
154 |
$383.25 |
| 87045 |
|
29 |
28 |
$379.65 |
| 84436 |
|
60 |
52 |
$365.91 |
| 85379 |
|
44 |
40 |
$314.24 |
| 87046 |
|
132 |
111 |
$288.06 |
| 80164 |
|
26 |
24 |
$176.08 |
| 84450 |
|
39 |
28 |
$171.56 |
| 87116 |
|
12 |
12 |
$137.14 |
| 83013 |
|
13 |
13 |
$102.02 |
| 82947 |
|
30 |
27 |
$101.74 |
| 84478 |
|
13 |
12 |
$60.71 |
| 85018 |
|
24 |
24 |
$54.89 |
| 86308 |
|
12 |
12 |
$53.16 |
| 3051F |
|
131 |
131 |
$0.00 |
| 3044F |
|
74 |
74 |
$0.00 |
| 3052F |
|
28 |
28 |
$0.00 |